National Institutes of Health: all 11,571 studies

Page 39 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Plasmodium and Other Parasites in Pregnant Women and Children Around Margibi and Montserrado Counties, LiberiaCompletedNCT03719599
• Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP TrialActive, not recruitingNCT03712605Phase 3
• Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical ResearchCompletedNCT03709303
• State and Trait Mediated Response to TMS in Substance Use DisorderWithdrawnNCT03707600Not applicable
• Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyCompletedNCT03707574
• Daratumumab, Bortezomib, and Dexamethasone With or Without Venetoclax in Treating Patients With Relapsed or Refractory Multiple MyelomaWithdrawnNCT03701321Phase 1/2
• Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic LeukemiaActive, not recruitingNCT03701282Phase 3
• Clinical Laboratory Evaluation of Chronic Autonomic FailureCompletedNCT03648905
• IFNL4 Genotype for Predicting Response to Ledipasvir/SofosbuvirWithdrawnNCT03639207
• Evaluation of a Novel PET Radioligand to Image OGACompletedNCT03632226
• Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology BranchCompletedNCT03627208
• Inpatient Challenge Study of rRSV A/Maryland/001/11, a Human Respiratory Syncytial Virus Challenge Strain, Administered to Healthy Adult VolunteersCompletedNCT03624790Phase 1
• Adult Patients With Undiagnosed Conditions and Their Responses to Clinically Uncertain Results From Exome SequencingCompletedNCT03605004
• Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing SurgerySuspendedNCT03604991Phase 2/3
• Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III MeningiomaActive, not recruitingNCT03604978Phase 1/2
• A Study to Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy AdultsCompletedNCT03603665Phase 1
• Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy ControlsCompletedNCT03602599
• Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast CancerActive, not recruitingNCT03598257Phase 2
• rCSP/AP10-602 [GLA-LSQ] Vaccine TrialCompletedNCT03589794Phase 1
• Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT03587311Phase 2
• A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus VaccineCompletedNCT03581903Phase 1
• Liver Transplantation With Tregs at MGHCompletedNCT03577431Phase 1/2
• Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype CorrelationCompletedNCT03575221
• Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis BWithdrawnNCT03575208Phase 2
• Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary HypertensionCompletedNCT03572036
• Denosumab Treatment for Fibrous DysplasiaActive, not recruitingNCT03571191Phase 2
• Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis PatientsActive, not recruitingNCT03568383Phase 3
• Vaginal Microbiome Exposure and Immune Responses in C-section InfantsActive, not recruitingNCT03567707Early Phase 1
• Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in ChildrenCompletedNCT03534245
• Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic AstrocytomaActive, not recruitingNCT03528642Phase 1
• People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral AgentsActive, not recruitingNCT03520660Phase 4
• Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell LymphocytopeniaActive, not recruitingNCT03519464Phase 2
• Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell TransplantCompletedNCT03511794
• Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)TerminatedNCT03507218
• Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered With HIV DNA CON-S Env Vaccine in Healthy, HIV-1-Uninfected AdultsWithdrawnNCT03505060Phase 1
• Tolerance by Engaging Antigen During Cellular HomeostasisCompletedNCT03504241Phase 1
• Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and LymphomaActive, not recruitingNCT03502733Phase 1
• Safety and Pharmacokinetics Study of DM1157 to Treat MalariaTerminatedNCT03490162Phase 1
• Biomarkers in Obstetrical ComplicationsCompletedNCT03480139
• Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest ImagingCompletedNCT03478917
• Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)CompletedNCT03478839
• A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy AdultsCompletedNCT03473002Phase 1
• H5N1 With or Without Topical Aldara in Healthy AdultsCompletedNCT03472976Phase 1
• Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope GlycoproteinTerminatedNCT03462004Phase 1
• Modulation of the Parieto-frontal CommunicationWithdrawnNCT03434093Not applicable
• Near-infrared Spectroscopy and Electroencephalography to Assess Cortical Activation During Motor Tasks in Infants and Toddlers With and Without Cerebral PalsyTerminatedNCT03434080
• Imaging Biomarker for Addiction Treatment OutcomeTerminatedNCT03427424
• Gait Disorders in Parkinson's DiseaseWithdrawnNCT03416452Early Phase 1
• Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 ChallengeCompletedNCT03416036Phase 1
• Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapyTerminatedNCT03407040
• Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and AlprazolamCompletedNCT03398083Phase 1
• Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 DiabetesWithdrawnNCT03396484Phase 2
• Point-of-Use Pathogen Identification Tool for DiarrheaTerminatedNCT03394040
• Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative AdultsCompletedNCT03393468Phase 1
• Qualitative Assessment of the Work-Sleep RelationshipCompletedNCT03389828
• Comparison of Naloxone PharmacokineticsCompletedNCT03386591Phase 1
• Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast CancerWithdrawnNCT03377101Phase 2
• Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic ChangesActive, not recruitingNCT03375307Phase 2
• Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular DegenerationCompletedNCT03372746
• Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in AdultsCompletedNCT03372733Phase 2
• Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-OnCompletedNCT03367767
• Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory PathologyCompletedNCT03366142Phase 1/2
• Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a StrokeCompletedNCT03366129
• Mothers Experiences With X-linked Retinoschisis Compared to Fathers ExperiencesCompletedNCT03354403
• Development of Non-Invasive Brain Stimulation TechniquesCompletedNCT03351764Not applicable
• Gut Microbiome and p-Inulin in CKD - TarGut CKD StudyStatus unknownNCT03348592Not applicable
• dbGaP Protocol: The Pediatric Cardiac Genetics Consortium (PCGC)CompletedNCT03347214
• Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder CancerCompletedNCT03327883
• Oral Health Needs Assessment of Sjogren s Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers Evaluating Oral Health Disparities as Determinants of Oral Health in a High-Risk PopulationCompletedNCT03327870
• Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by SurgeryWithdrawnNCT03326258Phase 1/2
• Evaluation of a Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1)CompletedNCT03324646
• Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell LymphomaActive, not recruitingNCT03321643Phase 1
• Serum, Dietary and Supplemental Vitamin D's Association With Cognitive DeclineCompletedNCT03320109
• Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined ImmunodeficiencyStatus unknownNCT03315078Phase 1/2
• Low-Dose Danazol for the Treatment of Telomere Related DiseasesCompletedNCT03312400Phase 2
• Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT StudyActive, not recruitingNCT03309033
• Community Dynamics of Malaria Transmission and Mosquito Feeding in Bancoumana, MaliCompletedNCT03304704
• Molecular Basis of Erythrocyte Invasion by Plasmodium Vivax Into Duffy-Negative Erythrocytes in MaliCompletedNCT03304691
• A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051CompletedNCT03301090Phase 1
• PREDICT Cytomegalovirus (CMV)CompletedNCT03300882
• Chart Review: Central Motor Conduction Time in Neurological DisordersCompletedNCT03300856
• Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive EpisodesCompletedNCT03289923Not applicable
• Clopidogrel Prevention of Early Arteriovenous (AV) Fistula ThrombosisCompletedNCT03289520Phase 3
• Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2Active, not recruitingNCT03284385Phase 2
• Vitamin D-related Genes and Metabolic DisordersCompletedNCT03279432
• Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With CirrhosisActive, not recruitingNCT03278925Phase 1
• Natural History of Intestinal Inflammation in People With Primary Immune DysregulationsWithdrawnNCT03278912
• Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular LymphomaActive, not recruitingNCT03269669Phase 2
• Internet-Based and Self-Reports in Assessing Diet and Physical Activity Within AARPCompletedNCT03268577
• Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in People With Functional Movement DisordersCompletedNCT03263013
• Photic Blink Reflex in People With Blepharospasm and Increased BlinkingTerminatedNCT03263000
• Characteristics and Outcomes of a Capacity-to-Consent Assessment ServiceCompletedNCT03258606
• Interhemispheric Interaction of Parieto-Motor Cortico-Cortical PlasticityWithdrawnNCT03253731
• Technical Development of Clinical Laboratory StudiesWithdrawnNCT03253718
• Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)CompletedNCT03253692
• Rare CNS Tumors Outcomes &RiskCompletedNCT03251989
• Questionnaire Pre-Test StudyCompletedNCT03248635
• Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C InfectionCompletedNCT03248622
• Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial CancerActive, not recruitingNCT03244384Phase 3
• Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial CancerActive, not recruitingNCT03237780Phase 2

← National Institutes of Health overview and focus areas